Table 3. Subhazard ratios of ischemic bowel syndrome in association with gender, age and co-morbidities in competing risk (death) models.
| Crude | Adjusted† | |||
|---|---|---|---|---|
| Variable | SHR | (95% CI) | SHR | (95% CI) |
| Sex (male vs female) | 1.01 | (0.87, 1.18) | 0.96 | (0.82, 1.12) |
| Age, years | 1.02 | (1.01, 1.02)*** | 1.01 | (1.01, 1.02)*** |
| Baseline comorbidities (no vs yes) | ||||
| Diabetes | 1.93 | (1.60, 2.33)*** | 1.37 | (1.12, 1.67)*** |
| Hypertension | 2.65 | (2.24, 3.15)*** | 1.78 | (1.46, 2.17)*** |
| Hyperlipidemia | 1.78 | (1.36, 2.34)*** | 0.97 | (0.73, 1.30) |
| COPD | 2.13 | (1.68, 2.70)*** | 1.29 | (1.00, 1.66) |
| Heart failure | 3.77 | (2.90, 4.88)*** | 1.90 | (1.41, 2.56)*** |
| CAD | 2.64 | (2.16, 3.21)*** | 1.45 | (1.15, 1.83)** |
| Stroke | 2.36 | (1.91, 2.92)*** | 1.46 | (1.16, 1.83)** |
| ESRD | 8.80 | (5.64, 13.7)*** | 5.27 | (3.34, 8.31)*** |
| AF | 2.78 | (1.84, 4.19)*** | 1.38 | (0.90, 2.12) |
Crude SHR, relative subhazard ratio; Adjusted SHR†: multivariable analysis including age, and co-morbidities (diabetes, hypertension, hyperlipidemia, COPD, heart failure, CAD, stroke, ESRD and AF).
**p<0.01
***p<0.001.